NewsWatch: Full FDA approval of Pfizer’s and Moderna’s COVID-19 shots would reinvigorate the U.S. vaccination push — but it could still be months away

No Comments
Uncategorized

The “full” approval of Pfizer and Moderna’s COVID-19 vaccines sometime this year could boost sagging vaccination rates in the U.S., though the Food and Drug Administration’s decision may not happen until the end of the year.

The “full” approval of Pfizer and Moderna’s COVID-19 vaccines sometime this year could boost sagging vaccination rates in the U.S., though the Food and Drug Administration’s decision may not happen until the end of the year.